Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NRSily: Silibinin in Chronic Hepatitis C Nonresponders
NCT00684268Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2007
- Primary completion
- Feb 2011
- Countries
- 1
01
Overview
A Phase 2 trial of silibinin in hepatitis C (HCV), sponsored by Medical University of Vienna. Started Oct 2007; status: completed.
02
Drugs
silibinin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00684268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00684268.